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Acute ﬁbrinous and organizing pneumonia (AFOP) is a histological pattern characterized by intra-
alveolar ﬁbrin deposition and associated organizing pneumonia. AFOP has been associated with many
rheumatologic disorders in the literature but has not been described in association with Sjogren's
syndrome.
This paper shows a rare association of AFOP with Sjogren's syndrome. Patient's symptoms promptly
improved after treatment with steroid.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute ﬁbrinous and organizing pneumonia (AFOP) is a type of
acute or subacute lung injury characterized by a dominant histo-
logical pattern of patchy intra-alveolar ﬁbrin and organizing
pneumonia which does not meet the histologic criteria for pattern
of diffuse alveolar damage (DAD), organizing pneumonia (OP), or
eosinophilic pneumonia (EP) [1]. The histological pattern are
devoid of hyaline membrane, eosinophils, granulomatous inﬂam-
mation, extensive pneumonia or abscess [1]. Other minor features
include acute or chronic inﬂammation, type 2 pneumocyte hyper-
plasia and alveolar expansion with myxoid tissue [1].
This entity was ﬁrst published by Beasley et al., in 2002. The case
of 17 patients showed male and white predominance with average
age of 62 years. Average time to onset of symptoms was 19 days,
and the most common symptoms includes cough, shortness of
breath and constitutional symptoms like fatigue or malaise [1].
AFOP etiology could be idiopathic or due to a wide range of
medical conditions including rheumatologic diseases like anky-
losing spondylitis, systemic lupus erythematous, polymyositis,
polymyalgia and juvenile dermatomyositis [1,2].
Sjogren's syndrome is a slowly progressive autoimmune disor-
der that affects many organ systems. Sjogren's syndromenya), Viral.GANDHI@ahn.org
), Raghukumar.THIRUMALA@
Ltd. This is an open access article ucommonly present with symptoms related to decrease lacrimal and
salivary gland function [3]. Pulmonary involvement in Sjogren's
syndrome is common. Histological pattern seen in Sjogren's syn-
drome include nonspeciﬁc interstitial pneumonia, usual interstitial
pneumonia, organizing pneumonia, lymphocytic interstitial pneu-
monia, primary pulmonary lymphoma and diffuse interstitial
amyloidosis [4]. Noncaseating granulomas and bronchiolitis have
also been described [5].
Acute ﬁbrinous and organizing pneumonia has not been asso-
ciated with Sjogren's syndrome to date. We present a case report of
AFOP in a patient with Sjogren's syndrome.
2. Case report
We report a case of a 75-year-old female who presented with
worsening shortness of breath, wheezing and fatigue of about one
week duration. She also had productive cough with white sputum
of about three days duration. She was diagnosed of SSA and SSB
antibody positive Sjogren's syndrome about nine years before
presentation. Hermanifestations of Sjogren's syndrome include dry
skin, arthritis, rash and pulmonary hypertension in which she was
on 3 L of nasal cannula of oxygen at home. Her symptoms had been
controlled with mycophenolate mofetil 500mg twice daily,
hydroxychloroquine 200mg daily and prednisone 10mg daily.
Other past medical history includes pulmonary embolism, gastro-
esophagus reﬂux disease, hyperlipidemia and hypertension. She
had similar presentation about three months earlier for which she
was managed by increasing her prednisone dose. Her symptoms
improved and she was back to her baseline. She admits to notnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. CT scan showing bilateral multilobar areas of consolidation.
Fig. 3. Intra-alveolar ﬁbrin accumulation without hyaline membrane formation (he-
matoxylin-eosin, original magniﬁcation 100).
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She originally presented to our clinic on the day of admission
with shortness of breath, wheezing, fatigue and productive cough.
She was found to be tachypneic, hypoxemic and had diffuse
wheezes and rhonchi on lung examination. She was sent to the
hospital for further evaluation. She was subsequently admitted.
On admission, she was hypoxic and was placed on 5 L of nasal
cannula oxygen. CT angiogram of the chest was done to rule out
pulmonary embolism. There was no pulmonary embolism present;
however therewas bilateral multilobar areas of consolidation (Fig.1
and Fig. 2).
She was started of vancomycin, cepeﬁme and azithromycin for
possible pneumonia. She underwent bronchoscopy on hospital day
3, bronchioalveolar lavage (BAL) and transbronchial biopsy was
done at the time. BAL showed presence of alveola macrophages,
reactive pneumocytes with rare neutrophils and lymphocytes.
Transbronchial biospsy revealed fragments of lung parenchyma
with focal areas of organization with intraalveolar ﬁbrin accumu-
lation, reactive type II pneumocyte hyperplasia and associated focal
acute and chronic inﬂammation. These were consistent with the
diagnosis of acute ﬁbrinous and organizing pneumonia (Fig. 3,
Fig. 4).
Both BAL and transbronchial biopsy was negative for malignant
cells. All respiratory cultures grew normal respiratory ﬂora. Shewas
restarted on prednisone 40mg daily. She improved remarkably af-
ter 8 days of hospitalization and was discharged home. She was to
restart her mycophenolate mofetil and hydrochloroquine as infec-
tious diseaseworkupwas negative. Shewas to continue prednisone
40mg daily and taper by reduction of 10mg every 2 weeks.
3. Discussion
AFOP is a relatively new entity with less than 115 cases reported
in the literature up till 2015 [6]. AFOP have been associated with
rheumatologic disease, infections, drug reaction, environmental
exposures, autoimmune disease and lung transplantation [1,6].
We are reporting the ﬁrst case of AFOP associated with Sjogren's
syndrome.
Tissue histopathology is characterized by intra-alveolar ﬁbrin in
the form of ﬁbrin ‘‘balls’’ and organizing pneumonia with a patchy
distribution [1,7].
AFOP have histological pattern similar to DAD, OP and EP but has
its own distinct histopathology. AFOP pattern can be distinguished
from that of DAD because the ﬁbrin in AFOP is organized into balls
within the alveolar spaces and the classic hyaline membranes seen
in DAD are not seen in AFOP [1]. Histologically, EP may also have
prominent intra-alveolar ﬁbrin like AFOP, however the eosinophilsFig. 1. CT scan showing bilateral multilobar areas of consolidation.
Fig. 4. Organizing pneumonia with focal intra-alveolar ﬁbrin (hematoxylin-eosin,
original magniﬁcation 200).predominates in EP [1]. It also present acutely or subacutely just
like DAD or OP.
Our patient fulﬁlled the 3 major criteria including organization
of intra-alveolar ﬁbrin, organizing pneumonia and the distribution
was patchy. The histopathology pattern also fulﬁl at least two mi-
nor features including type II pneumocyte hyperplasia and pres-
ence of acute and chronic inﬂammation.
The clinical course and radiologic ﬁndings are similar to that of
OP. Patients with rapidly progressive disease have imaging ﬁndings
similar to DAD with diffuse but basilar-dependent consolidation
Table 1
Cases associated with rheumatologic disease are rare with only 8 cases published in the literature.
Author, year Age, sex Rheumatologic disorder Treatment Outcome
Sauter et al., 2014 [10] 66, F Antisynthetase syndrome Azathioprine Good
Mycophenolate
Steroid
Valim et al., 2012 [2] 39, F Undifferentiated connective tissue disease Cylophosphamide, steroid Death
Hariri et al., 2010 [11] 16, M SLE Steroid, cyclophosphamide, anticoagulants Good
Balduin et al., 2007 [12] 47, M Stigmata of rheumatoid disease Steroid Good
Prahalad et al., 2005 [13] 14, F Juvenile dermatomyositis Antibiotics, immunoglobulin, cyclophosphamide, steroid and cyclosporine Death
Beasley et al., 2002 [1] 55, M Ankylosing spondylitis Steroid Good
78, F Polymyositis Steroid Death
58, F Fibromyalgia Antibiotics Good
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imaging ﬁndings that mirror that of OP and can include both focal
and diffuse parenchymal abnormality [8]. AFOP can lead to pul-
monary ﬁbrosis on imaging just like DAD and OP [8].
The mainstay treatment in the literature for AFOP is steroids;
however other immunosuppresants and antibiotics have also been
used with varying results (Table 1). Overall, many cases responds to
steroids, however, therapeutic modality did not correlate with the
outcome [1].
The largest study of patients with AFOP involved a series of 22
patients that have undergone lung transplant. The prognosis was
worse in these group of patients versus those with obliterative
bronchiolitis [9].
Our patient had a favorable outcome after the diagnosis. How-
ever, long term outcome needs to be evaluated.
4. Conclusion
Although AFOP have been associated with other rheumatologic
disorders, this is the ﬁrst case associated with Sjogren's syndrome.
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